Indeed, blocking the CTLA-4 gene in CD8+ CTLs with elevated PD-1/CTLA-4 expression enhances IFN-γ production and cytotoxicity against bladder cancer cells [84]. The gene discussed is PDCD1; the disease is urinary bladder cancer.